TFS Capital’s DexCom DXCM Stock Holding History

TFS Capital’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-313,688	Closed	-$3.24M	–	1175
2014 Q1	$3.24M	Sell	313,688 -615,136	-66%	-$6.36M	0.21%	119
2013 Q4	$8.22M	Sell	928,824 -38,704	-4%	-$306K	0.39%	23
2013 Q3	$6.83M	Sell	967,528 -253,908	-21%	-$1.61M	0.31%	63
2013 Q2	$6.86M	Buy	+1,221,436	New	+$5.85M	0.29%	58

Other funds holding DXCM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

TFS Capital's DXCM Position: Q2 2014 in Review

TFS Capital sold out of DexCom (DXCM) in Q2 2014, closing a stake of 313,688 shares — an estimated $3.24M sold.

TFS Capital first reported a position in DXCM in Q2 2013 and held it in 4 quarters. The position peaked at $8.22M in Q4 2013. 190 funds tracked by Wall St. Rank hold DXCM as of Q2 2014.

TFS Capital reported no remaining DexCom position as of Q2 2014 after selling out during the quarter.
TFS Capital sold 313,688 DexCom shares in Q2 2014, an estimated $3.24M.
TFS Capital first reported a position in DexCom in Q2 2013 and held it in 4 quarters.
TFS Capital's DexCom position peaked at $8.22M in Q4 2013.
190 funds tracked by Wall St. Rank held DexCom as of Q2 2014.

Based on TFS Capital's 13F filing for Q2 2014, filed 21 Jul 2014.